Effectiveness, tolerability and safety of opicapone in fluctuating Parkinson's disease

被引：0
|
作者：
Marti-Andres, G. [1 ]
Armengou, L. [1 ]
Esparragosa, I. [1 ]
Toledano Illan, C. [1 ]
Valenti, R. [1 ]
Luquin, R. [1 ]
机构：
[1] Clin Univ Navarra, Neurol, Pamplona, Spain
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO1184
引用
收藏
页码：633 / 634
页数：2
相关论文
共 50 条
  • [41] Assessment of safety and efficacy of Opicapone add-on to levodopa in Parkinson's disease.
    Ruiz-Lopez, Marta
    Diaz, Lola
    Feliz, Cici
    Garcia-Ruiz, Pedro
    [J]. NEUROLOGY, 2020, 94 (15)
  • [42] COMT genotype and effectiveness of entacapone in patients with fluctuating Parkinson's disease
    Lee, MS
    Kim, HS
    Cho, EK
    Lim, JH
    Rinne, JO
    [J]. NEUROLOGY, 2002, 58 (04) : 564 - 567
  • [43] Efficacy and tolerability of a novel sublingual apomorphine preparation in patients with fluctuating Parkinson's disease
    Ondo, W
    Hunter, C
    Almaguer, M
    Gancher, S
    Jankovic, J
    [J]. CLINICAL NEUROPHARMACOLOGY, 1999, 22 (01) : 1 - 4
  • [44] Opicapone in Parkinson’s disease: a profile of its use
    Scott L.J.
    [J]. Drugs & Therapy Perspectives, 2017, 33 (7) : 303 - 310
  • [45] Addition of Opicapone to Safinamide in Parkinson's Disease patients
    Russo, M.
    Carrarini, C.
    Dono, F.
    Di Pietro, M.
    Rispoli, M.
    Ferri, L.
    Onofrj, M.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S80 - S80
  • [46] Opicapone (Ongentys) - A COMT Inhibitor for Parkinson's Disease
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1615): : 3 - 5
  • [47] Efficacy and safety/tolerability of opicapone in catechol-O-methyltransferase inhibitor-naive Parkinson's disease patients recently diagnosed with motor fluctuations
    Lees, A.
    Ferreira, J.
    Poewe, W.
    Gama, H.
    Magalhaes, D.
    Rocha, J. -F.
    Soares-da-Silva, P.
    [J]. MOVEMENT DISORDERS, 2020, 35 : S461 - S462
  • [48] EFFICACY AND SAFETY/TOLERABILITY OF OPICAPONE IN CATECHOL-O-METHYLTRANSFERASE INHIBITOR-NAIVE PARKINSON'S DISEASE PATIENTS RECENTLY DIAGNOSED WITH MOTOR FLUCTUATIONS
    Lees, A.
    Ferreira, J. J.
    Poewe, W.
    Gama, H.
    Magalhaes, D.
    Rocha, J. -F.
    Soares-da-Silva, P.
    [J]. PARKINSONISM & RELATED DISORDERS, 2020, 79 : E57 - E57
  • [49] EFFICACY AND SAFETY OF OPICAPONE IN PATIENTS OVER 70 YEARS WITH PARKINSON'S DISEASE AND MOTOR FLUCTUATIONS
    Lees, A.
    Ferreira, J.
    Costa, R.
    Santos, A.
    Rocha, J.
    Soares-Da-Silva, P.
    [J]. AGE AND AGEING, 2019, 48
  • [50] Efficacy and safety of opicapone in patients over 70 years with Parkinson's disease and motor fluctuations
    Lees, A.
    Ferreira, J.
    Lopes, N.
    Costa, R.
    Santos, A.
    Oliveira, C.
    Pinto, R.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    [J]. MOVEMENT DISORDERS, 2015, 30 : S99 - S99
12345